DOMINICI, Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 42.169
EU - Europa 22.096
AS - Asia 21.969
SA - Sud America 3.361
AF - Africa 583
OC - Oceania 116
Continente sconosciuto - Info sul continente non disponibili 30
Totale 90.324
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 41.267
SG - Singapore 6.820
IT - Italia 5.753
CN - Cina 5.659
GB - Regno Unito 4.930
SE - Svezia 3.442
HK - Hong Kong 2.733
VN - Vietnam 2.567
BR - Brasile 2.448
DE - Germania 2.041
FI - Finlandia 1.114
RU - Federazione Russa 939
FR - Francia 790
KR - Corea 709
TR - Turchia 624
UA - Ucraina 613
IN - India 548
IE - Irlanda 536
ID - Indonesia 496
CA - Canada 470
AR - Argentina 324
NL - Olanda 318
BG - Bulgaria 294
JP - Giappone 291
MX - Messico 290
BD - Bangladesh 261
PL - Polonia 187
ES - Italia 182
ZA - Sudafrica 172
IQ - Iraq 171
BE - Belgio 170
PK - Pakistan 143
AT - Austria 126
AE - Emirati Arabi Uniti 117
EC - Ecuador 117
AU - Australia 110
CO - Colombia 107
CL - Cile 105
VE - Venezuela 103
LT - Lituania 92
MY - Malesia 88
CZ - Repubblica Ceca 84
RO - Romania 80
MA - Marocco 75
UZ - Uzbekistan 68
KE - Kenya 67
PH - Filippine 64
TW - Taiwan 64
EG - Egitto 63
CH - Svizzera 62
IR - Iran 58
SA - Arabia Saudita 56
JO - Giordania 55
PE - Perù 48
PY - Paraguay 48
AL - Albania 46
DZ - Algeria 44
IL - Israele 44
TN - Tunisia 43
NO - Norvegia 41
TH - Thailandia 37
NP - Nepal 34
PT - Portogallo 33
SI - Slovenia 30
UY - Uruguay 30
AZ - Azerbaigian 27
LB - Libano 27
KZ - Kazakistan 25
RS - Serbia 25
DO - Repubblica Dominicana 24
BO - Bolivia 23
OM - Oman 23
BY - Bielorussia 22
CR - Costa Rica 22
JM - Giamaica 20
DK - Danimarca 19
HR - Croazia 19
SY - Repubblica araba siriana 19
ET - Etiopia 18
GR - Grecia 18
SN - Senegal 18
EU - Europa 16
QA - Qatar 16
SK - Slovacchia (Repubblica Slovacca) 16
CY - Cipro 15
NG - Nigeria 14
PA - Panama 14
EE - Estonia 13
HU - Ungheria 13
AM - Armenia 12
CI - Costa d'Avorio 12
KG - Kirghizistan 12
PS - Palestinian Territory 12
BZ - Belize 11
GE - Georgia 11
HN - Honduras 11
BH - Bahrain 10
LK - Sri Lanka 10
MD - Moldavia 10
KW - Kuwait 9
Totale 90.127
Salva come PNG Salva come JPEG
Città #
Ashburn 4.555
Singapore 4.372
Santa Clara 3.807
Fairfield 3.781
Southend 2.741
Hong Kong 2.653
Chandler 2.282
Woodbridge 1.978
Stockholm 1.834
Hefei 1.792
San Jose 1.700
Houston 1.590
Seattle 1.367
Wilmington 1.201
Cambridge 1.173
Ann Arbor 1.113
London 1.051
Beijing 1.050
Nyköping 979
Jacksonville 977
Los Angeles 896
Ho Chi Minh City 861
Dearborn 859
Chicago 840
Helsinki 837
Council Bluffs 751
Modena 687
Seoul 663
New York 662
Hanoi 613
The Dalles 579
Dallas 543
Munich 524
Dublin 499
Bologna 478
Milan 446
San Diego 430
Jakarta 360
Lauterbourg 320
Salt Lake City 318
Izmir 310
Princeton 306
Moscow 295
Shanghai 285
Sofia 279
Frankfurt am Main 242
Buffalo 225
São Paulo 222
Tokyo 215
Eugene 200
Rome 197
Orem 182
Parma 155
Tampa 152
Elk Grove Village 150
Phoenix 140
Reggio Emilia 139
Warsaw 137
Boardman 134
Redwood City 130
Des Moines 126
Berlin 125
Brussels 122
Nuremberg 120
Falls Church 119
Mexico City 115
Bremen 114
Columbus 113
Mcallen 109
Fremont 108
Guangzhou 108
Da Nang 106
Atlanta 103
Montréal 103
Montreal 102
Amsterdam 101
Chennai 101
Johannesburg 101
Rio de Janeiro 97
Brooklyn 94
Denver 94
Lancaster 94
Toronto 91
Haiphong 89
Kent 87
Manchester 86
Redondo Beach 76
Sterling 71
Miami 66
Turku 64
Poplar 63
Vienna 63
Portsmouth 61
Dong Ket 60
Naples 60
Baghdad 59
Hillsboro 59
Florence 58
Mumbai 58
Grafing 56
Totale 61.859
Salva come PNG Salva come JPEG
Nome #
A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology. 2.191
0.1 grams of sub-cutaneous adipose tissue (SCAT) as source of adult multipotent mesenchymal stromal cells (MSC) for cell-based therapies 701
Dynamic cultivation of mesenchymal stem cell aggregates 654
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement 511
CD271 Mediates Stem Cells to Early Progeny Transition in Human Epidermis 486
Impressive response to dose-dense chemotherapy in a patient with NUT midline carcinoma 465
Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy 458
Rigenerand srl - Spin off Università di Modena e Reggio Emilia 427
Adipose stromal/stem cells assist fat transplantation reducing necrosis and increasing graft performance. 424
GD2 expression in breast cancer. 419
MSC-delivered soluble TRAIl and paclitaxel as novel combinatory treatment for pancreatic adenocarcinoma 419
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer 410
Lack of confirmation of an association between HTLV-I infection and myelodysplastic syndrome 407
Autologous Porcine Bone Marrow Mesenchymal Cells for Reconstruction of a Resorbed Alveolar Bone: A Preclinical Model in Mini-Pigs 404
GMP-manufactured density gradient media for optimized mesenchymal stromal/stem cell isolation and expansion. 404
Impact of time to surgery after neoadjuvant chemotherapy in operable breast cancer patients 396
Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapy 392
Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies 384
A novel anti-GD2/4-1BB chimeric antigen receptor triggers neuroblastoma cell killing 380
The puzzling situation of hospital exemption for advanced therapy medicinal products in Europe and stakeholders' concerns 379
Predictors of human epidermal growth factor receptor 2 fluorescence in-situ hybridisation amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysis. 378
MSC and Tumors: Homing, Differentiation and Secretion Influence The Therapeutic Potentials 378
Delayed marrow infusion in mice enhances hematopoietic and osteopoietic engraftment by facilitating transient expansion of the osteoblastic niche 375
Interstitial Lung Disease in Abemaciclib-treated Patients during SARS-CoV-2 Pandemic: A Case Series. 374
cGMP-compliant transportation conditions for a prompt therapeutic use of marrow mesenchymal stromal/stem cells 373
SOLUBLE TRAIL-ARMED HUMAN AD-MSC AS NOVEL CELL THERAPY APPROACH FOR PANCREATIC DUCTAL ADENOCARCINOMA 373
Isolation, characterization, and transduction of endometrial decidual tissue multipotent mesenchymal stromal/stem cells from menstrual blood 372
Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells 364
A novel function for amniotic fluid: original or authentic? 363
Microglia are less pro-inflammatory than myeloid infiltrates in the hippocampus of mice exposed to status epilepticus 362
Suppression of invasion and metastasis of triple-negative breast cancer lines by pharmacological or genetic inhibition of slug activity 360
Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors 360
Le Cellule Staminali Mesenchimali: Aspetti Biologici ed Approcci Terapeutici 357
Altered pH gradient at the plasma membrane of osteosarcoma cells is a key mechanism of drug resistance 355
PCR con primer degenerati non evidenzia sequenze virali di HHV-8 ne di una sua variante in cellule stromali midollari di pazienti affetti da gammopatie monoclonali 350
Mesenchymal progenitors aging highlights a mir-196 switch targeting HOXB7 as master regulator of proliferation and osteogenesis 347
Proteomics Analysis of Formalin-Fixed Paraffine-Embedded Tissue Reveals Key Proteins Related to Lung Dysfunction in Idiopathic Pulmonary Fibrosis. 346
An alternative approach to investigate biofilm in medical devices: A feasibility study 343
Clinical Prognosticators in Patients Treated with CDK 4/6 Inhibitors for Hormone Receptors Positive Advanced Breast Cancer 343
Phase I study of intraperitoneal MHC unrestricted adoptive cell therapy with TALL-104 cells in patients with peritoneal carcinosis 341
Body composition and inflammation impact in non-small cell lung cancer patients treated by first-line immunotherapy 340
In vitro differentiation of human amniotic epithelial cells into insulin-producing 3D spheroids 339
Potency biomarker signature genes from multiparametric osteogenesis assays: Will cGMP human bone marrow mesenchymal stromal cells make bone? 337
Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: A joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT) 335
Correlating tumor-infiltrating lymphocytes and lung cancer stem cells: a cross-sectional study. 335
Transplanted murine long-term repopulating hematopoietic cells can differentiate to osteoblasts in the marrow stem cell niche 333
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 333
Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM 331
Human mesenchymal stem cell combined with a new strontium-enriched bioactive glass: An ex-vivo model for Bone Regeneration 330
Comparison of single and dual platform methodologies for the estimation of CD34+ hematopoietic progenitor cells: correlation with colony assay 329
Proteasome inhibitors sensitize colon carcinoma cells to TRAIL-induced apoptosis via enhanced release of Smac/DIABLO from the mitochondria 328
Clarification of the nomenclature for MSC: the international society for cellular therapy position statement 327
Osteopoietic engraftment after bone marrow transplantation: Effect of inbred strain of mice 327
Tumor Stroma Manipulation By MSC 327
In vitro anti-myeloma activity of TRAIL-expressing adipose-derived mesenchymal stem cells. 324
METHOD FOR PRODUCTION OF ANTI-TUMOR TRAIL PROTEIN 323
International society for cellular therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials 320
ALDH Expression in Angiosarcoma of the Lung: A Potential Marker of Aggressiveness? 319
Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas 318
Circulating mucosal-associated invariant T cells identify patients responding to anti-PD-1 therapy 318
Label-free toxicology screening of primary human mesenchymal cells and iPS-derived neurons 315
Cytokine-Induced Osteopoietic Differentiation of Transplanted Marrow Cells 313
Restoration and reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow radioablation 312
A new bioactive glass with extremely high crystallization temperature and outstanding biological performance 312
Integrated intErventional bronchoscopy in the treatment of locally adVanced non-small lung cancER with central Malignant airway Obstructions: a multicentric REtrospective study (EVERMORE). 311
Modulation of Mutational Landscape in HER2-Positive Breast Cancer after Neoadjuvant Chemotherapy 309
Angiogenesis in multiple myeloma: Correlation between in vitro endothelial colony growth (CFU-En) and clinical biological features 308
Overall survival in patients with lung adenocarcinoma harboring "niche" mutations: an observational study 308
Arming Mesenchymal Stromal/Stem Cells Against Cancer: Has the Time Come? 308
Transportation conditions for prompt use of Ex Vivo expanded and freshly harvested clinical-grade bone marrow mesenchymal stromal/stem cells for bone regeneration 307
Blocking tumor-educated MSC paracrine activity halts osteosarcoma progression 307
Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single Institution analysis 306
Feasibility and safety of treating non-unions in tibia, femur and humerus with autologous, expanded, bone marrow-derived mesenchymal stromal cells associated with biphasic calcium phosphate biomaterials in a multicentric, non-comparative trial 305
Nivolumab-Induced Impressive Response of Refractory Pulmonary Sarcomatoid Carcinoma with Brain Metastasis 305
Detection of microparticles from human red blood cells by multiparametric flow cytometry 303
Transgenic Mice with Pancellular Enhanced Green Fluorescent Protein Expression in Primitive Hematopoietic Cells and All Blood Cell Progeny 301
How do mesenchymal stromal cells exert their therapeutic benefit? 299
Inhibiting interactions of lysine demethylase LSD1 with Snail/Slug blocks cancer cell invasion. 296
Molecular mechanisms and cellular contribution from lung fibrosis to lung cancer development. 296
Cancer Stem-Like Cells in a Case of an Inflammatory Myofibroblastic Tumor of the Lung. 294
Cancer stem-neuroendocrine cells in an atypical carcinoid case report. 293
GD2 CAR T cells against human glioblastoma 291
Anti-GD2 CAR MSCs against metastatic Ewing's sarcoma 291
Bone marrow mesenchymal cells: biological properties and clinical applications. 289
Mineralization by mesenchymal stromal cells is variously modulated depending on commercial platelet lysate preparations 289
Precision Medicine in Lung Cancer: Challenges and Opportunities in Diagnostic and Therapeutic Purposes. 289
Cell therapies for pancreatic beta-cell replenishment. 288
Donor Cell-Derived Osteopoiesis Originates from a Self-Renewing Stem Cell with a Limited Regenerative Contribution after Transplantation 285
Understanding Tumor-Stroma Interplays for Targeted Therapies by Armed Mesenchymal Stromal Progenitors: The Mesenkillers. 285
Mesenchymal Stromal/Stem Cells from Tissue Repair to Destruction of Tumor Cells 283
Progress in characterization, preparation and clinical applications of non-hematopoietic stem cells, 29-30 September 2006, Tübingen, Germany 283
Basic research and clinical applications of non-hematopoietic stem cells, 4-5 April 2008, Tubingen, Germany. 282
Fibrotic idiopathic interstitial lung disease: the molecular and cellular key players. 282
Expression of HOXB7 in the lung of patients with idiopathic pulmonary fibrosis: a proof of concept study. 280
Rare breast cancer subtypes: Histological, molecular, and clinical peculiarities 280
Cell therapy for disorders of bone 280
Clinical-Pathological Characteristics of HER2+ Breast Cancers patients among BRCA1/2+ carriers tested in Modena Cancer Center. 280
17th Annual ISCT Meeting. May 18-21, 2011. Rotterdam 279
A new Approach to Investigate Biofilm Formation in Medical Devices 279
CD44+/EPCAM+ cells detect a subpopulation of ALDHhigh cells in human non-small cell lung cancer: A chance for targeting cancer stem cells? 279
Totale 36.300
Salva come PNG Salva come JPEG
Categoria #
all - tutte 344.605
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 344.605
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.224 0 0 0 0 0 0 0 0 0 0 792 432
2021/20226.659 365 738 581 348 284 474 400 410 653 525 1.072 809
2022/20237.308 824 784 544 663 742 907 191 654 1.160 136 404 299
2023/20245.124 257 309 365 495 823 502 513 600 154 196 287 623
2024/202516.829 497 226 488 1.146 2.697 2.488 1.410 981 1.964 1.134 1.625 2.173
2025/202634.275 2.334 1.402 3.053 4.292 5.756 2.171 4.231 1.802 5.062 3.557 615 0
Totale 91.078